By determining the ability of CD8+ T cells to form LDs in vivo during tumour progression, researchers discovered that although more than 20% of CD8+ T cells infiltrating early lesions carried LDs, the percentage of these cells carrying LDs decreased significantly by the later experimental time points. This evidence concerns the gene CD8A and neoplasm.